{"id":1883,"date":"2024-02-01T13:46:28","date_gmt":"2024-02-01T18:46:28","guid":{"rendered":"https:\/\/www.lifetein.com\/blog\/?p=1883"},"modified":"2024-11-16T16:32:33","modified_gmt":"2024-11-16T21:32:33","slug":"cyclic-peptides-as-antiviral-agents","status":"publish","type":"post","link":"https:\/\/www.lifetein.com\/blog\/cyclic-peptides-as-antiviral-agents\/","title":{"rendered":"Cyclic Peptides as Antiviral Agents"},"content":{"rendered":"\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"1024\" height=\"824\" src=\"https:\/\/www.lifetein.com\/blog\/wp-content\/uploads\/2024\/02\/Cyclic-Peptide1-1024x824.webp\" alt=\"Cyclic Peptides\" class=\"wp-image-1887\" srcset=\"https:\/\/www.lifetein.com\/blog\/wp-content\/uploads\/2024\/02\/Cyclic-Peptide1-1024x824.webp 1024w, https:\/\/www.lifetein.com\/blog\/wp-content\/uploads\/2024\/02\/Cyclic-Peptide1-300x241.webp 300w, https:\/\/www.lifetein.com\/blog\/wp-content\/uploads\/2024\/02\/Cyclic-Peptide1-768x618.webp 768w, https:\/\/www.lifetein.com\/blog\/wp-content\/uploads\/2024\/02\/Cyclic-Peptide1-1536x1236.webp 1536w, https:\/\/www.lifetein.com\/blog\/wp-content\/uploads\/2024\/02\/Cyclic-Peptide1-373x300.webp 373w, https:\/\/www.lifetein.com\/blog\/wp-content\/uploads\/2024\/02\/Cyclic-Peptide1.webp 1662w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Cyclic peptides are macromolecules with restricted structures that have stronger competitive edges than linear biological entities.\u00a0They have been reported to possess various activities, such as antifungal, antiviral, and antimicrobial activities.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Key Takeaways<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Cyclic peptides<\/strong>\u00a0are excellent examples of broad-spectrum antivirals.<\/li>\n\n\n\n<li>They have a unique conformational constraint that provides a larger surface area to interact with the target.<\/li>\n\n\n\n<li>Cyclic peptides improve the membrane permeability and in vivo stability compared to their linear counterparts.<\/li>\n\n\n\n<li>There is emerging interest in cyclic peptide therapeutics.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>The Antiviral Activity of Cyclic Peptides<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Overview<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Cyclic peptides have been found to neutralize a broad range of group 1 influenza A viruses, including H5N1.\u00a0The peptide design was based on complementarity-determining region (CDR) loops.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Advantages of Cyclic Peptides<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The unique conformational constraint of cyclic peptides provides a larger surface area to interact with the target at the same time, improving the membrane permeability and in vivo stability compared to their linear counterparts.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Applications in Antiviral Therapies<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Cyclic peptides have been reported to possess various activities, such as antifungal, antiviral, and antimicrobial activities.\u00a0To date, there is emerging interest in cyclic peptide therapeutics, and increasing numbers of clinically approved cyclic peptide drugs are available on the market.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Cyclic Peptides in Clinical Trials<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Current Status<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Several cyclic peptides are currently in clinical trials for various diseases, including viral infections. These trials are crucial steps in understanding the safety and efficacy of these potential therapeutics.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Challenges and Solutions<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Despite the promising potential of cyclic peptides, there are challenges in their development, such as their synthesis and delivery. However, advancements in peptide engineering and drug delivery technologies are helping to overcome these obstacles.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Future Directions<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Potential for Broad-Spectrum Antiviral Agents<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Given their unique properties and broad-spectrum antiviral activity, cyclic peptides hold great promise for the future of antiviral therapies. Their ability to target a wide range of viruses makes them particularly valuable in the face of emerging and re-emerging viral diseases.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Advancements in Research<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Research in the field of cyclic peptides is rapidly advancing, with new cyclic peptide-based drugs being developed and tested. These advancements are expected to further expand the potential applications of cyclic peptides in antiviral therapy.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img decoding=\"async\" width=\"503\" height=\"228\" src=\"https:\/\/www.lifetein.com\/blog\/wp-content\/uploads\/2024\/02\/Cyclic-Peptide2.webp\" alt=\"Cyclic Peptides\" class=\"wp-image-1886\" srcset=\"https:\/\/www.lifetein.com\/blog\/wp-content\/uploads\/2024\/02\/Cyclic-Peptide2.webp 503w, https:\/\/www.lifetein.com\/blog\/wp-content\/uploads\/2024\/02\/Cyclic-Peptide2-300x136.webp 300w, https:\/\/www.lifetein.com\/blog\/wp-content\/uploads\/2024\/02\/Cyclic-Peptide2-500x227.webp 500w\" sizes=\"(max-width: 503px) 100vw, 503px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Frequently Asked Questions<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>What are cyclic peptides?<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Cyclic peptides are macromolecules with restricted structures that have stronger competitive edges than linear biological entities.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>How do cyclic peptides work as antiviral agents?<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Cyclic peptides have been found to neutralize a broad range of group 1 influenza A viruses, including H5N1.\u00a0The peptide design was based on complementarity-determining region (CDR) loops.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>What are the advantages of cyclic peptides?<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The unique conformational constraint of cyclic peptides provides a larger surface area to interact with the target at the same time, improving the membrane permeability and in vivo stability compared to their linear counterparts.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Are there any cyclic peptide drugs on the market?<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Yes, there are increasing numbers of clinically approved cyclic peptide drugs available on the market.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">For more information, you can visit\u00a0<a href=\"https:\/\/www.lifetein.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">LifeTein&#8217;s homepage. <\/a><br \/><br \/>Chia, L. Y., Kumar, P. V., Maki, M. A. A., Ravichandran, G., &amp; Thilagar, S. (2022). A Review: The Antiviral Activity of Cyclic Peptides. In International Journal of Peptide Research and Therapeutics (Vol. 29, Issue 1). Springer Science and Business Media LLC. https:\/\/doi.org\/10.1007\/s10989-022-10478-y<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cyclic peptides are macromolecules with restricted structures that have stronger competitive edges than linear biological entities.\u00a0They have been reported to possess various activities, such as antifungal, antiviral, and antimicrobial activities. Key Takeaways The Antiviral Activity of Cyclic Peptides Overview Cyclic &hellip; <a href=\"https:\/\/www.lifetein.com\/blog\/cyclic-peptides-as-antiviral-agents\/\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":6,"featured_media":2133,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_crdt_document":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[4],"tags":[],"class_list":["post-1883","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-peptide_synthesis"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.lifetein.com\/blog\/wp-json\/wp\/v2\/posts\/1883","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.lifetein.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.lifetein.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.lifetein.com\/blog\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.lifetein.com\/blog\/wp-json\/wp\/v2\/comments?post=1883"}],"version-history":[{"count":0,"href":"https:\/\/www.lifetein.com\/blog\/wp-json\/wp\/v2\/posts\/1883\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.lifetein.com\/blog\/wp-json\/wp\/v2\/media\/2133"}],"wp:attachment":[{"href":"https:\/\/www.lifetein.com\/blog\/wp-json\/wp\/v2\/media?parent=1883"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.lifetein.com\/blog\/wp-json\/wp\/v2\/categories?post=1883"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.lifetein.com\/blog\/wp-json\/wp\/v2\/tags?post=1883"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}